Unknown

Dataset Information

0

Late intervention with the small molecule BB3 mitigates postischemic kidney injury.


ABSTRACT: Ischemia-reperfusion-mediated acute kidney injury can necessitate renal replacement therapy and is a major cause of morbidity and mortality. We have identified BB3, a small molecule, which when first administered at 24 h after renal ischemia in rats, improved survival, augmented urine output, and reduced the increase in serum creatinine and blood urea nitrogen. Compared with control kidneys, the kidneys of BB3-treated animals exhibited reduced levels of kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and reduced tubular apoptosis and acute tubular necrosis but enhanced tubular regeneration. Consistent with its hepatocyte growth factor-like mode of action, BB3 treatment promoted phosphorylation of renal cMet and Akt and upregulated renal expression of the survival protein Bcl-2. These data suggest that the kidney is amenable to pharmacotherapy even 24 h after ischemia-reperfusion and that activation of the hepatocyte growth factor signaling pathway with the small molecule BB3 confers interventional benefits late into ischemia-reperfusion injury. These data formed, in part, the basis for the use of BB3 in a clinical trial in kidney recipients presenting with delayed graft function.

SUBMITTER: Narayan P 

PROVIDER: S-EPMC5008674 | biostudies-other | 2016 Aug

REPOSITORIES: biostudies-other

altmetric image

Publications

Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Narayan Prakash P   Duan Bin B   Jiang Kai K   Li Jingsong J   Paka Latha L   Yamin Michael A MA   Friedman Scott L SL   Weir Matthew R MR   Goldberg Itzhak D ID  

American journal of physiology. Renal physiology 20160601 2


Ischemia-reperfusion-mediated acute kidney injury can necessitate renal replacement therapy and is a major cause of morbidity and mortality. We have identified BB3, a small molecule, which when first administered at 24 h after renal ischemia in rats, improved survival, augmented urine output, and reduced the increase in serum creatinine and blood urea nitrogen. Compared with control kidneys, the kidneys of BB3-treated animals exhibited reduced levels of kidney injury molecule-1, neutrophil gelat  ...[more]

Similar Datasets

| S-EPMC3266792 | biostudies-literature
| S-EPMC10278989 | biostudies-literature
| S-EPMC5698058 | biostudies-literature
| S-EPMC3755983 | biostudies-literature
| S-EPMC2885849 | biostudies-literature
| S-EPMC3880280 | biostudies-literature
| S-EPMC4895577 | biostudies-literature
| S-EPMC7494813 | biostudies-literature
| S-EPMC5020909 | biostudies-literature
| S-EPMC9745129 | biostudies-literature